A9543RR — Y90 Ibritumomab, Rx
Cite this view
HANK Price Transparency. (n.d.). Y90 ibritumomab, rx (HCPCS A9543RR) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/A9543RR?code_type=HCPCS
“Y90 ibritumomab, rx (HCPCS A9543RR) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/A9543RR?code_type=HCPCS. Accessed .
“Y90 ibritumomab, rx (HCPCS A9543RR) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/A9543RR?code_type=HCPCS.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $130,953–$130,953 (25th–75th percentile) across 1 hospital · 1 payer.
“Negotiated” is the hospital’s negotiated facility rate for this HCPCS A9543RR — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| BELLIN MEMORIAL HOSPITAL OutpatientFacility | Anthem | PPO | $130,953.16 | — | — | 2025-06-27 | MRF ↗ |
| BELLIN MEMORIAL HOSPITAL OutpatientFacility | ANTHEM | HMO/POS | $130,953.16 | — | — | 2025-06-27 | MRF ↗ |
| BELLIN MEMORIAL HOSPITAL OutpatientFacility | ANTHEM | PRIORITY | $130,953.16 | — | — | 2025-06-27 | MRF ↗ |